Ledger.Open graph →

SEC Form D · filed June 5, 2018

Adaptive Phage Therapeutics, Inc

Offering

$5.0M

Sold

$2.4M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

GAITHERSBURG, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Gregory L. Merril · Gaithersburg, MDExec · Director Carl L. Merril · Gaithersburg, MDExec · Director William L. Mutryn · Gaithersburg, MDDirector Maren Steinberg · DENVER, COExec · Director Thomas Spicer · Luxembourg, LuxembourgExec · Director Matt Belcher · San Diego, CADirector Tyler Engh · Chicago, ILDirector Guillermo Guefen · Houston, TXExec · Director Nick P. Steinsberger · Tulsa, OKExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗